Graham Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,114
Closed -$250K 1124
2025
Q4
$250K Sell
3,114
-1,084
-26% -$90.8K 0.01% 946
2025
Q3
$410K Buy
+4,198
New +$338K 0.01% 701
2025
Q2
Sell
-5,526
Closed -$274K 1268
2025
Q1
$274K Buy
5,526
+348
+7% +$22K ﹤0.01% 1027
2024
Q4
$362K Buy
5,178
+2,363
+84% +$196K 0.01% 855
2024
Q3
$295K Buy
2,815
+1,231
+78% +$144K 0.01% 784
2024
Q2
$225K Sell
1,584
-22,987
-94% -$2.65M ﹤0.01% 829
2024
Q1
$2.74M Buy
24,571
+22,821
+1,304% +$2.72M 0.05% 194
2023
Q4
$227K Buy
+1,750
New +$241K 0.01% 803
2023
Q2
Sell
-21,609
Closed -$2.88M 936
2023
Q1
$2.88M Buy
+21,609
New +$2.54M 0.09% 165
2022
Q3
Sell
-29,020
Closed -$1.59M 1038
2022
Q2
$1.59M Buy
+29,020
New +$1.68M 0.06% 281
2022
Q1
Sell
-2,772
Closed -$206K 878
2021
Q4
$206K Buy
+2,772
New +$164K 0.01% 461

Other funds holding ACLS

Graham Capital Management's ACLS Position: Q1 2026 in Review

Graham Capital Management sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 3,114 shares — an estimated $250K sold.

Graham Capital Management first reported a position in ACLS in Q4 2021 and held it in 11 quarters. The position peaked at $2.88M in Q1 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Graham Capital Management reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 3,114 Axcelis shares in Q1 2026, an estimated $250K.
  • Graham Capital Management first reported a position in Axcelis in Q4 2021 and held it in 11 quarters.
  • Graham Capital Management's Axcelis position peaked at $2.88M in Q1 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.